4DMedical Limited
FDMDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $1 |
| % Growth | 2.2% | -2.2% | 273.7% | – |
| Cost of Goods Sold | $0 | $0 | $19 | $14 |
| Gross Profit | $3 | $3 | -$16 | -$13 |
| % Margin | 90.7% | 93.5% | -525.6% | -1,616.8% |
| R&D Expenses | $2 | $0 | $3 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17 | $15 | $6 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $16 | $9 | $11 |
| Operating Income | -$16 | -$13 | -$25 | -$24 |
| % Margin | -553.3% | -443.9% | -832.8% | -2,972.5% |
| Other Income/Exp. Net | $5 | -$6 | $3 | $5 |
| Pre-Tax Income | -$11 | -$19 | -$22 | -$18 |
| Tax Expense | $0 | $0 | -$2 | -$3 |
| Net Income | -$11 | -$19 | -$20 | -$16 |
| % Margin | -368.5% | -662% | -687.8% | -1,969.3% |
| EPS | -0.047 | -0.031 | -0.068 | -0.042 |
| % Growth | -52.6% | 54.4% | -61.9% | – |
| EPS Diluted | -0.17 | -0.031 | -0.068 | -0.042 |
| Weighted Avg Shares Out | 62 | 618 | 300 | 372 |
| Weighted Avg Shares Out Dil | 230 | 618 | 300 | 372 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $0 | $4 |
| EBITDA | -$24 | -$22 | -$22 | -$10 |
| % Margin | -797.7% | -775.4% | -749.2% | -1,219.8% |